HGA
DGX icon

Hobbs Group Advisors’s Quest Diagnostics DGX Stock Holding History

Hobbs Group Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$18K Buy
+130
New +$17.1K 0.01% 292

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hobbs Group Advisors's DGX Position: Q4 2023 in Review

Hobbs Group Advisors opened a new position in Quest Diagnostics (DGX) in Q4 2023: 130 shares worth $18K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings.

826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Hobbs Group Advisors held 130 shares of Quest Diagnostics worth $18K as of Q4 2023.
  • Quest Diagnostics was a new Hobbs Group Advisors position in Q4 2023.
  • Quest Diagnostics made up 0.01% of Hobbs Group Advisors's portfolio in Q4 2023, its #292 holding.
  • 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Hobbs Group Advisors's 13F filing for Q4 2023, filed 16 Feb 2024.